Tag Archives: BNT162b2

Pfizer-BioNTech says its COVID vaccine 100% effective in teens Berlin, Germany | Xinhua | German biotechnology company BioNTech and U.S. company Pfizer said on Wednesday that their COVID-19 vaccine was 100-percent efficient in children aged between 12 and 15. The BNT162b2 vaccine was “well tolerated” and elicited robust antibody responses that …

Mainz, Germany | THE INDEPENDENT | Drug companies Pfizer and BioNTech have conclude Phase 3 Study of their COVID-19 Vaccine candidate BNT162b2 , whose primary efficacy analysis demonstrates it to be 95% effective against COVID-19 beginning 28 days after the first dose. According to a statement, efficacy was consistent across …